Dr. Christensen CURRICULUM VITAE

Ryan D. Christensen, M.D.

NAME

• Ryan D. Christensen, M.D.

BIRTHDATE

• April 16, 1977; Garden City, Kansas

WORK HISTORY

2010 - PRESENT:

• Retina Associates, P.A.
  Santa Fe Medical Building
  9301 West 74th Street
  Suite 210
  Shawnee Mission, KS 66204
• Retina Associates, P.A.
  6201 College Boulevard
  Suite 200
  Overland Park, KS 66211
• Retina Associates. P.A.
  10100 N Ambassador Drive
  Suite 100
  Kansas City, MO 64153
• Retina Associates, P.A.
  6001 SW 6th Avenue
  Suite 300
  Topeka, KS 66615
• Retina Associates, P.A.
  3700 W 10th Street
  Suite 101
  Sedalia, MO 65301
• Retina Associates, P.A.
  100 NE Missouri Road
  Suite 203
  Lee's Summit, MO 64086

EDUCATION:

• Retina Associates, P.A. – Shawnee Mission, KS 2008-2010
  -Vitreoretinal Fellowship
• University of Kansas School of Medicine – Kansas City, KS 2005-2008
  -Ophthalmology residency
• University of Kansas School of Medicine – Wichita, KS 2003-2004
  -Internal Medicine internship
• University of Kansas School of Medicine – Wichita, KS 2002-2004
  -Clinical clerkship – medical school
• University of Kansas School of Medicine – Kansas City, KS 2000-2002
  -Basic science clerkship – medical school
• Kansas State University – Manhattan, KS 1995-2000
  -Bachelor of Science – Biology
• Garden City Community College – Garden City, KS 1996-1997
• Garden City High School – Garden City, KS 1991-1995

RESEARCH:

• Eyetech: EOP1024, Sub-Investigator,
  Evaluating the effects of Intravitreal
  Injections of Pegaptanib for NVAMD
  on the corneal endothelium 2010-present
• Genentech: FVF4168g, Sub-Investigator,
  Intravitreal Injection of Ranibizumab for
  Diabetic Macular Edema 2008-present
• Genentech: FVF4166g, Sub-Investigator,
  Intravitreal Injection of Ranibizumab for
  Central Retinal Vein Occlusion 2008-2010
• Genentech: FVF4165g, Sub-Investigator,
  Intravitreal Injection of Ranibizumab for
  Branch Retinal Vein Occlusion 2008-2010
• Genentech: FVF3426g, Sub-Investigator,
  Intravitreal Injection of Ranibizumab for
  BRVO & CRVO patients who completed
  Genentech sponsored Ranibizumab Study 2009-2010
• Genentech: FVF4579g, Sub-Investigator,
  Intravitreal Injection of Ranibizumab for
  Subfoveal Neovascular AMD 2009-present
• Genentech: FVF4967g, Sub-Investigator,
  Intravitreal Injection of Ranibizumab for
  BRVO, CRVO, & HRVO study to start 2/2011
• Ophthotech: OPH3000, Sub-Investigator,
  Intravitreal Injection of Volocixumab in
  combination with Ranibizumab for NVAMD 2008-2009
• Ophthotech: OPH1001, Sub-Investigator,
  Intravitreal Injection of E10030 in
  combination with Ranibizumab for NVAMD 2010-present

SCHOLARLY PRESENTATIONS

• “Fluorescein Angiography #101” 2008/09
  -KU Eye
  -Monthly lecture series
• “Posterior Parasitic Uveitis” 11/2007
  -KU Eye Grand Rounds
• “Parasitic Uveitis: Worm in the Eye!!" 02/2007
  -High Plain’s Eye Society Winter Symposium
• “Adherence to Preferred Practice Patterns in ARMD” 06/2007
  -KU Eye Grand Rounds
• “AAO Mid-Year Forum 2007” 06/2007
  -KU Eye Grand Rounds
• “Orbital Masses – A Differential Diagnosis” 05/2007
  -Children’s Mercy Hospital Grand Rounds
• "Eyelid Tumors - Clinical Diagnosis and Histology 101" 09/2006
  -KU Eye Grand Rounds
• "Herpetic Corneal Disorders" 07/2006
  -KU Eye New Resident Orientation
• "Common Corneal Disorders" 07/2006
  -KU Eye New Resident Orientation
• "Cogan's Syndrome - Oculovestibuloauditory Syndrome" 06/2006
  -KU Eye Resident Research Day
• "LASIK and Excimer Laser Evolution" 03/2006
  -KU Eye Grand Rounds
• "Aceruloplasminemia – Fundus and Fluorescein Angiography" 04/2006
  - KU Medical Center Internal Medicine Grand Rounds
• "The Red Eye - A Differential Diagnosis" 07/2005
  -KU Medical Center Pediatrics Morning Report